CoinVoice has recently learned that Hong Kong listed company HuaJian Medical has announced the establishment of a wholly-owned subsidiary, IVD GROUP, in the state of New York, USA. This U.S. subsidiary will be the core operational entity to advance the IVDNewCo Exchange strategy in the United States.

In addition, the U.S. subsidiary has officially launched the process of applying for a stablecoin license with relevant U.S. regulatory agencies (including but not limited to the SEC and CFTC).

This move is a substantial advancement of the group's "U.S. stablecoin license application plan" mentioned in the previous announcement, demonstrating the group's execution capability and foresight in global compliance layout. [Original link]